Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 8/20 | 0.43 |
| ▸ | CA2 | P00918 | 8/20 | 0.43 |
| ▸ | CA9 | Q16790 | 7/20 | 0.43 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA7 | P43166 | 3/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.43 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.43 |
| ▸ | CA3 | P07451 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | CA6 | P23280 | 2/20 | 0.43 |
| ▸ | CA5A | P35218 | 2/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL55803 | 1.00 | CA1 (0.43) | CA1CA2CA9LPAR3CA12 | |
| SCHEMBL2855857 | 1.00 | CA1 (0.43) | CA1CA2CA9LPAR3CA12 | |
| SCHEMBL93201 | 1.00 | CA1 (0.43) | CA1CA2CA9LPAR3CA12 | |
| SCHEMBL2858733 | 1.00 | CA1 (0.43) | CA1CA2CA9LPAR3CA12 | |
| SCHEMBL2862726 | 1.00 | CA1 (0.43) | CA1CA2CA9LPAR3CA12 | |
| SCHEMBL68307 | 1.00 | CA1 (0.43) | CA1CA2CA9LPAR3CA12 | |
| SCHEMBL157306 | 1.00 | CA1 (0.43) | CA1CA2CA9LPAR3CA12 | |
| SCHEMBL2855746 | 1.00 | CA1 (0.43) | CA1CA2CA9LPAR3CA12 | |
| SCHEMBL77312 | 1.00 | CA1 (0.43) | CA1CA2CA9LPAR3CA12 | |
| SCHEMBL104986 | 1.00 | CA1 (0.43) | CA1CA2CA9LPAR3CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11179471-B2 | Peptide for cytosolic delivery | KYOTO UNIVERSITY (JP) | 2021-11-23 | — | — | US | disclosed |
| WO-2021020462-A1 | INTRACELLULAR DELIVERY PEPTIDE | 国立大学法人京都大学 | 2021-02-04 | — | — | WO | disclosed |
| US-10730904-B2 | Method for liquid-phase synthesis of nucleic acid | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-08-04 | — | — | US | disclosed |
| US-20200046840-A1 | PEPTIDE FOR CYTOSOLIC DELIVERY | KYOTO UNIVERSITY (JP) | 2020-02-13 | — | — | US | disclosed |
| EP-3604520-A1 | PEPTIDE FOR CYTOSOLIC DELIVERY | Kyoto University (JP) | 2020-02-05 | — | — | EP | disclosed |
| EP-2921499-B1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACIDS | TAKEDA PHARMACEUTICALS CO (JP) | 2020-01-22 | — | — | EP | disclosed |
| CN-105924556-B | Polymer comprising phthalocyanine structure, the method for preparing polymer, color compositions, pigment dispersion and toner | 佳能株式会社 | 2019-08-30 | — | — | CN | disclosed |
| US-20190135852-A1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACID | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2019-05-09 | — | — | US | disclosed |
| EP-3061775-B1 | POLYMER INCLUDING PHTHALOCYANINE STRUCTURE, METHOD FOR PRODUCING THE POLYMER, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER | CANON KK (JP) | 2018-12-12 | — | — | EP | disclosed |
| US-9829814-B2 | Toner | CANON KABUSHIKI KAISHA (JP) | 2017-11-28 | — | — | US | disclosed |
| US-5667959-A | Silver halide photographic material and hydroxamic acid based compound used therefor | FUJI PHOTO FILM CO., LTD. (JP) | 1997-09-16 | — | — | US | disclosed |
| EP-0698814-A2 | Silver halide photographic material with improved latent image stability | FUJI PHOTO FILM CO., LTD. (JP) | 1996-02-28 | — | — | EP | disclosed |
| US-4952470-A | CONTAINING OZONE RESISTANCE ADDITIVE | KONICA CORPORATION (JP) | 1990-08-28 | — | — | US | disclosed |
| EP-0034950-B1 | HETEROCYCLIC 4- AND 6-EQUIVALENT PHOTOGRAPHIC COLOUR COUPLERS AND PHOTOGRAPHIC MATERIALS AND DEVELOPER COMPOSITIONS CONTAINING THEM | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1986-01-08 | — | — | EP | disclosed |
| US-4410696-A | Antitumor and immunosuppressive 4-carbamoylimidazolium-5-olate derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1983-10-18 | — | — | US | disclosed |
| EP-0075629-A1 | Imidazole derivatives, their preparation, and their pharmaceutical compositions | Sumitomo Chemical Industries Ltd. (JP) | 1983-04-06 | — | — | EP | disclosed |
| US-4338393-A | COLOR PHOTOGRAPHY | EASTMAN KODAK COMPANY (US) | 1982-07-06 | — | — | US | disclosed |
| US-4314011-A | DISCOLORATION INHIBITORS | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1982-02-02 | — | — | US | disclosed |
| EP-0034950-A2 | Heterocyclic 4- and 6-equivalent photographic colour couplers and photographic materials and developer compositions containing them | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1981-09-02 | — | — | EP | disclosed |
| US-4254216-A | ANTIFADING ADDITIVE FOR FILMS | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1981-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190135852-A1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACID | RNGTT, POLR2H, POLR2E | CA1 4486/4885CA2 4503/4885CA9 3880/4885 |
| US-10730904-B2 | Method for liquid-phase synthesis of nucleic acid | RNGTT, POLR2H, POLR2E | CA1 4503/4885CA2 4489/4885CA9 4189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.